These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1260850)

  • 1. Effects of intravenous glucose during pacing-induced angina pectoris in patients with coronary artery disease.
    Zir LM; Nocero MM; Rose M; Weisinger B; Krauss K; Glassman E
    Cathet Cardiovasc Diagn; 1976; 2(1):49-57. PubMed ID: 1260850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal and cardiac metabolic effects of low-dose glucose infusion during pacing in patients with and without coronary artery disease.
    Thomassen A; Nielsen TT; Bagger JP; Henningsen P
    Am Heart J; 1989 Jul; 118(1):25-32. PubMed ID: 2662729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiischemic and metabolic effects of glutamate during pacing in patients with stable angina pectoris secondary to either coronary artery disease or syndrome X.
    Thomassen A; Nielsen TT; Bagger JP; Pedersen AK; Henningsen P
    Am J Cardiol; 1991 Aug; 68(4):291-5. PubMed ID: 1858669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary heart disease. Differential hemodynamic, metabolic, and electrocardiographic effects in subjects with and without angina pectoris during atrial pacing.
    Helfant RH; Forrester JS; Hampton JR; Haft JI; Kemp HG; Gorlin R
    Circulation; 1970 Oct; 42(4):601-10. PubMed ID: 11993303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial pacing in coronary artery disease, including preinfarction angina and postoperative studies.
    Linhart JW
    Am J Cardiol; 1972 Nov; 30(6):603-10. PubMed ID: 4538844
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of ranolazine on ischemic threshold, coronary sinus blood flow, and myocardial metabolism in coronary artery disease.
    Bagger JP; Bøtker HE; Thomassen A; Nielsen TT
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):479-84. PubMed ID: 9310277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right atrial pacing in coronary heart disease.
    Frick MH
    Adv Cardiol; 1973; 8():193-202. PubMed ID: 4565882
    [No Abstract]   [Full Text] [Related]  

  • 8. Myocardial function during atrial pacing in patients with angina pectoris and normal coronary arteriograms. Comparison with patients having significant coronary artery disease.
    Arbogast R; Bourassa MG
    Am J Cardiol; 1973 Sep; 32(3):257-63. PubMed ID: 4725578
    [No Abstract]   [Full Text] [Related]  

  • 9. Beneficial effects of diltiazem in coronary artery disease.
    Kenny J; Daly K; Bergman G; Kerkez S; Jewitt DE
    Br Heart J; 1984 Jul; 52(1):53-6. PubMed ID: 6743423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional myocardial perfusion during atrial pacing in patients with coronary artery disease.
    Schmidt DH; Weiss MB; Casarella WJ; Fowler DL; Sciacca RR; Cannon PJ
    Circulation; 1976 May; 53(5):807-19. PubMed ID: 1260985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left heart hemodynamics during angina pectoris induced by atrial pacing.
    Linhart JW; Hildner FJ; Barold SS; Listejw ; Samet P
    Circulation; 1969 Oct; 40(4):483-92. PubMed ID: 4980883
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of myocardial ischemia in pacing-induced elevation of arterial pressure.
    Loeb HS; Croke RP; Gunnar RM
    Chest; 1978 Oct; 74(4):381-5. PubMed ID: 699647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of nitroglycerin on myocardial metabolism and hemodynamics during angina induced by atrial pacing.
    Chiong MA; West RO; Parker JO
    Circulation; 1972 May; 45(5):1044-56. PubMed ID: 4623192
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of low-dose dobutamine on coronary hemodynamics, myocardial metabolism, and anginal threshold in patients with coronary artery disease.
    Pacold I; Kleinman B; Gunnar R; Loeb HS
    Circulation; 1983 Nov; 68(5):1044-50. PubMed ID: 6616788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effect of glucose-insulin-potassium on the response to atrial pacing.
    Chiong MA; West R; Parker JO
    Circulation; 1976 Jul; 54(1):37-46. PubMed ID: 1277428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic accompaniments of angina: a comparison during angina induced by exercise and by atrial pacing.
    O'Brien KP; Higgs LM; Glancy DL; Epstein SE
    Circulation; 1969 Jun; 39(6):735-43. PubMed ID: 5785288
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic and hemodynamic effects of nicardipine during pacing-induced angina pectoris.
    Thomassen A; Bagger JP; Nielsen TT; Henningsen P
    Am J Cardiol; 1987 Feb; 59(4):219-24. PubMed ID: 3812268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of glucose on myocardial substrate utilization in acute myocardial infarction or angina pectoris.
    Martinez EE; Telles JS; Martinez TL; Portugal OP; Guimaraes RF; Herrmann JL; Lamounier EN; Caio AA; Auriemo RC; Ambrose JA
    Am J Cardiol; 1987 Nov; 60(13):947-51. PubMed ID: 3673912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Course of coronary disease. Evaluation of prognosis and progression of coronary insufficiency with atrial pacing and ergometry].
    Kugler G; Johannes E; Rödiger W; Westermann KW
    Z Kardiol; 1975 Mar; 64(3):245-54. PubMed ID: 1130129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diltiazem during tachycardia-induced angina pectoris.
    Joyal M; Cremer K; Pieper J; Feldman RL; Pepine CJ
    Am J Cardiol; 1986 Jan; 57(1):10-4. PubMed ID: 3942050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.